Oscar Health, Inc.
OSCR- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001568651
In the last 90 days, Oscar Health, Inc. insiders filed 0 open-market purchases and 10 sales; 403 institutions reported holding it in 13F filings for Q2 2026, worth $5.65B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Oscar Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 10 filings
- 7 insiders, $64.0M in total
- Insiders trading
- 7
- Net value
- −$64.0M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Oscar Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wittman Vanessa Ames | Director | 112,121 | Sep 22, 2026 | 2 |
| Kushner Joshua | Co-Founder and Vice Chairman | 0Indirect | Sep 18, 2026 | 1 |
| Thrive Capital Partners II, L.P. | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Thrive Capital Partners III, L.P. | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Claremount TW, L.P. | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Thrive Capital Partners VII Growth, L.P. | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Claremount VII Associates, L.P. | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Thrive Partners III GP, LLC | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Thrive Partners II GP, LLC | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Thrive Partners VII GP, LLC | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Thrive Partners VII Growth GP, LLC | Director, 10% Owner | 0Indirect | Sep 18, 2026 | 1 |
| Liang Janet | President, Oscar Insurance | 248,697 | Sep 8, 2026 | 4 |
| Baltrus Victoria | Chief Accounting Officer | 213,631 | Sep 8, 2026 | 4 |
| Blackley Richard Scott | Chief Financial Officer | 1,046,108 | Sep 8, 2026 | 8 |
| McAnaney Adam | Chief Legal Officer | 209,004 | Sep 8, 2026 | 4 |
| Schlosser Mario | Director | 449,444 | Sep 8, 2026 | 12 |
| Gassen William | Director | 82,840 | Jul 13, 2026 | 5 |
| Sankaran Sid | Director | 22,609 | Jul 13, 2026 | 3 |
| Plouffe David | Director | 137,121 | Jul 13, 2026 | 5 |
| Bertolini Mark T | Chief Executive Officer | 7,751,570 | Jul 1, 2026 | 4 |
| Lang Laura W | Director | 82,840 | Jun 8, 2026 | 1 |
| Boyd Jeffery H | Director | 705,673 | Apr 13, 2026 | 3 |
| Robinson Elbert O. Jr. | Director | 64,512 | May 14, 2025 | 0 |
| Quane Alessandrea C. | EVP, Chief Insurance Officer | 430,216 | Dec 9, 2024 | 0 |
| Bopitiya Ranmali | EVP & Chief Legal Officer | 241,488 | Dec 3, 2024 | 0 |
| Wolin Steven | Chief Operating Officer | 102,598 | Dec 3, 2024 | 0 |
| Alphabet Inc. | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| CapitalG LP | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| CapitalG GP LLC | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| GV 2014 GP, L.L.C. | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| GV 2014, L.P. | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| CapitalG 2015 LP | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| CapitalG 2015 GP LLC | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| Alphabet Holdings LLC | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| Verily Life Sciences LLC | 10% Owner | 0Indirect | Aug 21, 2023 | 0 |
| Weaver Dennis | Chief Clinical Officer | 27,110 | Dec 5, 2022 | 0 |
| Phillips Jr Charles E | Director | 85,787 | Oct 18, 2022 | 0 |
| Joyce Meghan V. | Chief Operating Officer | 43,070 | Mar 3, 2022 | 0 |
| Klein Joel | Chief Policy & Strat. Officer | 17 | Aug 20, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2021 (view filing) | Aug 20-24 | 4 days | Kushner JoshuaCo-Founder and Vice Chairman | PPurchaseClass A Common Stock | +1.27M | $12.76 | +$16.2M | New position1.27M after | 3 lots |
| Aug 24, 2021 (view filing)8:43 PM ET | Aug 20-24 | 4 days | Thrive Capital Partners VII Growth, L.P. and 3 others10% Owner | PPurchaseClass A Common Stock | +1.27M | $12.76 | +$16.2M | +253,656.8%1.27M after | 3 lots |
| Aug 27, 2021 (view filing) | Aug 25-27 | 2 days | Kushner JoshuaCo-Founder and Vice Chairman | PPurchaseClass A Common Stock | +454.2K | $13.85 | +$6.29M | +35.8%1.72M after | 3 lots |
| Aug 27, 2021 (view filing)8:32 PM ET | Aug 25-27 | 2 days | Thrive Capital Partners VII Growth, L.P. and 3 others10% Owner | PPurchaseClass A Common Stock | +454.2K | $13.85 | +$6.29M | +35.8%1.72M after | 3 lots |
| Sep 1, 2021 (view filing) | Aug 30-31 | 2 days | Kushner JoshuaCo-Founder and Vice Chairman | PPurchaseClass A Common Stock | +635.4K | $15.00 | +$9.53M | +36.9%2.36M after | 4 lots |
| Sep 1, 2021 (view filing)7:56 PM ET | Aug 30-31 | 2 days | Thrive Capital Partners VII Growth, L.P. and 3 others10% Owner | PPurchaseClass A Common Stock | +635.4K | $15.00 | +$9.53M | +36.9%2.36M after | 4 lots |
| Sep 2, 2021 (view filing) | Sep 1 | 1 day | Weaver DennisChief Clinical Officer | SSaleClass A Common Stock | −3.03K | $17.21 | −$52.1K | −36.3%5.32K after | |
| Sep 2, 2021 (view filing) | Sep 1 | 1 day | Joyce Meghan V.Chief Operating Officer | SSaleClass A Common Stock | −24.0K | $17.17 | −$412.3K | −40.9%34.7K after | |
| Sep 7, 2021 (view filing) | Sep 2-3 | 5 days | Kushner JoshuaCo-Founder and Vice Chairman | PPurchaseClass A Common Stock | +485.5K | $18.07 | +$8.77M | +20.6%2.84M after | 3 lots |
| Sep 7, 2021 (view filing)4:15 PM ET | Sep 2-3 | 5 days | Thrive Capital Partners VII Growth, L.P. and 3 others10% Owner | PPurchaseClass A Common Stock | +485.5K | $18.07 | +$8.77M | +20.6%2.84M after | 3 lots |
| Sep 16, 2021 (view filing) | Sep 14-15 | 2 days | Kushner JoshuaCo-Founder and Vice Chairman | PPurchaseClass A Common Stock | +839.1K | $18.01 | +$15.1M | +21.4%4.76M after | 2 lots |
| Sep 16, 2021 (view filing)5:39 PM ET | Sep 14-15 | 2 days | Thrive Capital Partners VII Growth, L.P. and 3 others10% Owner | PPurchaseClass A Common Stock | +839.1K | $18.00 | +$15.1M | +21.4%4.76M after | 2 lots |
| Sep 17, 2021 (view filing) | Sep 16 | 1 day | Schlosser MarioChief Executive Officer | PPurchaseClass A Common Stock | +57.3K | $17.53 | +$1.00M | +337,058.8%57.3K after | |
| Sep 28, 2021 (view filing) | Sep 9-13 | 19 days | Kushner JoshuaCo-Founder and Vice Chairman | PPurchaseClass A Common Stock | +1.07M | $17.47 | +$18.7M | +37.7%3.92M after | Amended5 lots |
| Sep 28, 2021 (view filing)6:30 PM ET | Sep 9-13 | 19 days | Thrive Capital Partners VII Growth, L.P. and 3 others10% Owner | PPurchaseClass A Common Stock | +1.07M | $17.46 | +$18.7M | +37.7%3.92M after | Amended5 lots |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Joyce Meghan V.Chief Operating Officer | SSaleClass A Common Stock | −3.09K | $8.75 | −$27.0K | −7.4%38.6K after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Weaver DennisChief Clinical Officer | SSaleClass A Common Stock | −2.41K | $8.79 | −$21.2K | −21.0%9.08K after | |
| Dec 3, 2021 (view filing)5:10 PM ET | Dec 2 | 1 day | Blackley Richard ScottChief Financial Officer | SSaleClass A Common Stock | −2.09K | $8.81 | −$18.4K | −29.8%4.92K after | |
| Dec 7, 2021 (view filing) | Dec 7 | Same day | Blackley Richard ScottChief Financial Officer | SSaleClass A Common Stock | −86.2K | – | – | −33.8%168.8K after | |
| Feb 17, 2022 (view filing) | Feb 16 | 1 day | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −49.4K | $7.18 | −$354.4K | −37.4%82.7K after | |
| Mar 3, 2022 (view filing) | Mar 2 | 1 day | Blackley Richard ScottChief Financial Officer | SSaleClass A Common Stock | −2.60K | $6.91 | −$18.0K | −1.5%173.2K after | |
| Mar 3, 2022 (view filing) | Mar 2 | 1 day | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −2.68K | $6.92 | −$18.5K | −3.0%87.0K after | |
| Mar 3, 2022 (view filing) | Mar 2 | 1 day | Joyce Meghan V.Chief Operating Officer | SSaleClass A Common Stock | −2.54K | $6.91 | −$17.6K | −5.6%43.1K after | |
| Mar 3, 2022 (view filing) | Mar 2 | 1 day | Weaver DennisChief Clinical Officer | SSaleClass A Common Stock | −1.89K | $6.94 | −$13.1K | −12.4%13.4K after | |
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Blackley Richard ScottChief Financial Officer | SSaleClass A Common Stock | −19.2K | $7.33 | −$140.8K | −8.1%216.5K after | |
| Mar 11, 2022 (view filing) | Mar 10 | 1 day | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −11.6K | $8.30 | −$96.6K | −9.8%106.6K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −2.56K | $4.69 | −$12.0K | −2.2%111.1K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Blackley Richard ScottChief Financial Officer | SSaleClass A Common Stock | −2.13K | $4.69 | −$10.0K | −1.0%221.4K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Weaver DennisChief Clinical Officer | SSaleClass A Common Stock | −1.55K | $4.69 | −$7.26K | −7.9%18.0K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Baltrus VictoriaChief Accounting Officer | SSaleClass A Common Stock | −1.22K | $4.69 | −$5.73K | −29.7%2.90K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Bopitiya RanmaliEVP & Chief Legal Officer | SSaleClass A Common Stock | −5.96K | $4.69 | −$28.0K | −29.2%14.5K after | |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Blackley Richard ScottChief Financial Officer | SSaleClass A Common Stock | −19.5K | $5.01 | −$97.9K | −6.9%264.3K after | |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −11.3K | $5.01 | −$56.6K | −7.9%131.0K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Weaver DennisChief Clinical Officer | SSaleClass A Common Stock | −1.60K | $5.85 | −$9.34K | −6.6%22.6K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Blackley Richard ScottChief Financial Officer | SSaleClass A Common Stock | −2.21K | $5.85 | −$12.9K | −0.8%269.1K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −2.95K | $5.85 | −$17.2K | −2.1%135.1K after | |
| Sep 6, 2022 (view filing) | Sep 2 | 4 days | Bopitiya RanmaliEVP & Chief Legal Officer | SSaleClass A Common Stock | −6.17K | $5.85 | −$36.1K | −17.7%28.7K after | |
| Sep 7, 2022 (view filing) | Sep 6 | 1 day | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −17.5K | $5.53 | −$97.0K | −10.5%148.8K after | |
| Sep 7, 2022 (view filing) | Sep 6 | 1 day | Blackley Richard ScottChief Financial Officer | SSaleClass A Common Stock | −31.6K | $5.53 | −$174.8K | −9.5%300.0K after | |
| Oct 5, 2022 (view filing) | Oct 3 | 2 days | Baltrus VictoriaChief Accounting Officer | SSaleClass A Common Stock | −11.7K | $4.96 | −$58.2K | −44.7%14.5K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Weaver DennisChief Clinical Officer | SSaleClass A Common Stock | −1.62K | $2.84 | −$4.61K | −5.7%27.1K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Blackley Richard ScottChief Transformation Officer | SSaleClass A Common Stock | −3.37K | $2.84 | −$9.57K | −1.1%303.6K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −3.81K | $2.84 | −$10.8K | −2.4%152.0K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Bopitiya RanmaliEVP & Chief Legal Officer | SSaleClass A Common Stock | −6.28K | $2.84 | −$17.8K | −12.8%42.9K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Baltrus VictoriaChief Accounting Officer | SSaleClass A Common Stock | −2.79K | $2.84 | −$7.92K | −11.9%20.7K after | |
| Dec 7, 2022 (view filing) | Dec 6 | 1 day | Blackley Richard ScottChief Transformation Officer | SSaleClass A Common Stock | −31.4K | $2.64 | −$82.9K | −8.6%334.8K after | |
| Dec 7, 2022 (view filing) | Dec 6 | 1 day | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −17.5K | $2.64 | −$46.1K | −9.5%165.8K after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Baltrus VictoriaChief Accounting Officer | SSaleClass A Common Stock | −3.48K | $4.75 | −$16.5K | −11.8%26.1K after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Bopitiya RanmaliEVP & Chief Legal Officer | SSaleClass A Common Stock | −7.25K | $4.75 | −$34.4K | −11.5%56.0K after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Quane Alessandrea C.EVP, Chief Insurance Officer | SSaleClass A Common Stock | −3.27K | $4.75 | −$15.5K | −1.9%169.6K after |